Brucellosis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(2 intermediate revisions by 2 users not shown)
Line 101: Line 101:
==Reference==
==Reference==
{{reflist|2}}
{{reflist|2}}
[[Category:Bacterial diseases]]
 
[[Category:Occupational diseases]]
[[Category:Zoonoses]]
[[Category:Infectious disease]]
[[Category:Biological weapons]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Pulmonology]]
[[Category:Hepatology]]
[[Category:Rheumatology]]
[[Category:Nephrology]]

Latest revision as of 20:44, 29 July 2020

Brucellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Brucellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Principles of diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Brucellosis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Brucellosis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Brucellosis natural history, complications and prognosis

CDC on Brucellosis natural history, complications and prognosis

Brucellosis natural history, complications and prognosis in the news

Blogs on Brucellosis natural history, complications and prognosis

Directions to Hospitals Treating Brucellosis

Risk calculators and risk factors for Brucellosis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Danitza LukacVishal Devarkonda, M.B.B.S[3]

Overview

If left untreated, patients with brucellosis may progress to develop focal organ complications, relapses or chronic brucellosis.[1] Common complications of brucellosis include granulomatous hepatitis, arthritis, sacroiliitis, meningitis, orchitis, epididymitis uveitis, and endocarditis. The prognosis of brucellosis is good with adequate treatment.

Natural History

If left untreated, patients with brucellosis may progress to develop focal organ involvement, relapses and chronic brucellosis.[2]

Complications

Complications of brucellosis include the following:[3][4][5][6][7][8][9][10][11]

Complications of Brucellosis
Osteoarticular
Cardiovascular
Hepatobiliary complications
Genitourinary Orchitis and epididymitis
Neurological
Gastrointestinal Colitis, ileitis, and spontaneous bacterial peritonitis.
  • Rare cases have been reported.
Respiratory tract
Pregnancy Spontaneous abortion
Cutaneous
Opthalmic Uveitis
  • Most frequent ophtalmic complications[12]

Prognosis

The prognosis of brucellosis is good with treatment. Mortality is less then 1%, usually due to consequence of cardiac involvement or severe neurologic disease.[13]

Reference

  1. Brucellosis. CDC. http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/brucellosis. Accessed on February 3, 2016
  2. Brucellosis. CDC. http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/brucellosis. Accessed on February 3, 2016
  3. Colmenero JD, Reguera JM, Martos F, Sánchez-De-Mora D, Delgado M, Causse M; et al. (1996). "Complications associated with Brucella melitensis infection: a study of 530 cases". Medicine (Baltimore). 75 (4): 195–211. PMID 8699960.
  4. Mantur BG, Amarnath SK, Shinde RS (2007). "Review of clinical and laboratory features of human brucellosis". Indian J Med Microbiol. 25 (3): 188–202. PMID 17901634.
  5. Overturf ML, Druihet RE, Fitz A (1979). "The effects of kallikrein, plasmin, and thrombin on hog kidney renin". J Biol Chem. 254 (23): 12078–83. PMID 159304.
  6. Doganay M, Aygen B. Human brucellosis: An overview. Int J Infect Dis 2003; 7:173.
  7. Young EJ (1995). "Brucellosis: current epidemiology, diagnosis, and management". Curr Clin Top Infect Dis. 15: 115–28. PMID 7546364.
  8. Zamani A, Kooraki S, Mohazab RA, Zamani N, Matloob R, Hayatbakhsh MR; et al. (2011). "Epidemiological and clinical features of Brucella arthritis in 24 children". Ann Saudi Med. 31 (3): 270–3. doi:10.4103/0256-4947.81543. PMC 3119967. PMID 21623056.
  9. Mousa AM, Bahar RH, Araj GF, Koshy TS, Muhtaseb SA, al-Mudallal DS; et al. (1990). "Neurological complications of brucella spondylitis". Acta Neurol Scand. 81 (1): 16–23. PMID 2330811.
  10. Pappas G, Bosilkovski M, Akritidis N, Mastora M, Krteva L, Tsianos E (2003). "Brucellosis and the respiratory system". Clin Infect Dis. 37 (7): e95–9. doi:10.1086/378125. PMID 13130417.
  11. Herrick JA, Lederman RJ, Sullivan B, Powers JH, Palmore TN (2014). "Brucella arteritis: clinical manifestations, treatment, and prognosis". Lancet Infect Dis. 14 (6): 520–6. doi:10.1016/S1473-3099(13)70270-6. PMC 4498663. PMID 24480149.
  12. FAO/WHO/OIE Brucellosis in humans and animals. WHO (2006). http://www.who.int/csr/resources/publications/Brucellosis.pdf Accessed on February 3, 2016
  13. Brucellosis "Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J. Larry Jameson, Joseph Loscalzo"Harrison's Principles of Internal Medicine, 19e Accessed on December 9th, 2017